LWPC
GILD icon

Legacy Wealth Partners (California)’s Gilead Sciences GILD Stock Holding History

Legacy Wealth Partners (California)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$1.4M Buy
20,305
+2,685
+15% +$179K 0.78% 31
2021
Q1 		$1.14M Buy
+17,620
New +$1.14M 0.67% 40

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Legacy Wealth Partners (California)'s GILD Position: Q2 2021 in Review

Legacy Wealth Partners (California) increased its Gilead Sciences (GILD) stake by 15% in Q2 2021, buying an estimated $179K and bringing the position to 20,305 shares worth $1.4M. The position accounts for 0.78% of the portfolio, ranked #31.

Legacy Wealth Partners (California) first reported a position in GILD in Q1 2021 and has held it in 2 quarters since. 1,545 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • Legacy Wealth Partners (California) held 20,305 shares of Gilead Sciences worth $1.4M as of Q2 2021.
  • Legacy Wealth Partners (California) bought 2,685 Gilead Sciences shares in Q2 2021, an estimated $179K.
  • Gilead Sciences made up 0.78% of Legacy Wealth Partners (California)'s portfolio in Q2 2021, its #31 holding.
  • Legacy Wealth Partners (California) first reported a position in Gilead Sciences in Q1 2021 and has held it in 2 quarters since.
  • 1,545 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Legacy Wealth Partners (California)'s 13F filing for Q2 2021, filed 16 Aug 2021.